Hybrid Conferencee

International Conference on Oncology and Cancer Therapeutics Development (ICOCTD - 26)

5th - 6th August 2026 | Glasgow, UK
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Glasgow. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Glasgow event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Glasgow conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Glasgow, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Glasgow."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Call for Paper

The ICOCTD aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.

The conference highlights advancements in Oncology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.

Authors are invited to submit papers addressing, but not limited to, the following areas:

01
Emerging cancer therapeutics and treatments
02
Novel drug development in oncology
03
Combination therapies for cancer
04
Immunotherapy advancements in cancer care
05
Targeted therapies in oncology
06
Challenges in cancer drug approval
07
Role of clinical trials in therapeutics
08
Patient access to new treatments
09
Biomarkers in therapeutic decision-making
10
Pharmacogenomics in cancer treatment
11
Cost-effectiveness of cancer therapies
12
Innovations in radiation oncology
13
Palliative care and cancer therapeutics
14
Ethical considerations in drug development
15
Role of technology in cancer therapeutics
16
Long-term outcomes of cancer treatments
17
Global access to cancer therapies
18
Patient adherence to cancer treatment
19
Future trends in cancer therapeutics
20
Collaboration in drug development research